tiprankstipranks
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market
AJANTPHARM
Ajanta Pharma Limited
RESEARCH TOOLSreports

Ajanta Pharma Limited (AJANTPHARM) Income Statement

5 Followers

Ajanta Pharma Limited Income Statement

Last quarter (Q2 2026), Ajanta Pharma Limited's total revenue was ₹13.54B, an increase of 14.08% from the same quarter last year. In Q2, Ajanta Pharma Limited's net income was ₹2.60B. See Ajanta Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 45.88B₹ 41.62B₹ 37.08B₹ 32.84B₹ 28.45B
Gross Profit
₹ 34.60B₹ 30.46B₹ 25.91B₹ 23.97B₹ 21.63B
Operating Expenses
₹ 23.32B₹ 20.01B₹ 19.11B₹ 15.86B₹ 12.71B
Depreciation and Amortization
₹ 1.44B₹ 1.35B₹ 1.30B₹ 1.25B₹ 1.16B
EBITDA
₹ 13.54B₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B
Operating Income
₹ 11.28B₹ 10.46B₹ 6.80B₹ 8.12B₹ 8.92B
Other Income/Expenses
₹ 607.00M₹ 682.90M₹ 654.90M₹ 976.00M₹ 79.40M
Pretax Income
₹ 11.89B₹ 11.14B₹ 7.45B₹ 9.09B₹ 9.00B
Net Income
₹ 9.20B₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B
Per Share Metrics
Basic EPS
₹ 73.56₹ 64.82₹ 45.89₹ 54.97₹ 50.06
Diluted EPS
₹ 73.53₹ 64.77₹ 45.89₹ 54.96₹ 50.06
Weighted Average Shares Outstanding
 125.17M 125.92M 128.12M 129.66M 130.62M
Weighted Average Shares Outstanding (Diluted)
 125.17M 126.01M 128.12M 129.66M 130.62M
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History